Form 4: Olesen Fund Reduces SODI Stake via 10b5-1 Plan

Olesen Value Fund L.P. and related entities reported planned sales of Solitron Devices Inc. common stock totaling 4,220 shares in early August 2025 under a Rule 10b5-1 plan.

Summary

• Olesen Value Fund L.P., along with Olesen Value Fund GP LLC, Olesen Capital Management LLC, and Christian Olesen, collectively reported planned sales of Solitron Devices Inc. (SODI) common stock.
• On August 8, 2025, 1,500 shares of common stock were sold at a price of $16.5 per share.
• On August 11, 2025, an additional 2,720 shares of common stock were sold at a price of $16.21 per share.
• Following these transactions, the reporting persons beneficially own 252,288 shares of Solitron Devices Inc. common stock.
• The transactions were made pursuant to a contract, instruction, or written plan for the sale of equity securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 4

Explanation: The sentiment is moderately negative due to insider selling, even though it's a planned transaction under Rule 10b5-1(c). While not as alarming as an unplanned sale, it still indicates a reduction in insider holdings.

Positives

• The sales were conducted under a Rule 10b5-1 plan, indicating pre-scheduled transactions rather than reactive selling.
• Despite the sales, the reporting persons collectively retain a significant beneficial ownership of 252,288 shares, demonstrating continued, albeit reduced, interest in the company.

Negatives

• Key insiders, including a 10% owner and director, are reducing their stake in the company by selling a total of 4,220 shares of common stock.
• The sales occurred at prices of $16.5 and $16.21 per share, potentially signaling that the insiders view these price levels as opportune for divestment.

Future Outlook

No forward-looking statements or guidance are provided beyond the scheduled transaction dates.

Industry Context

This filing is an insider transaction report and does not provide broader industry context or trends.

Related Party Transactions

• The filing is a joint report by Olesen Value Fund L.P., Olesen Value Fund GP LLC, Olesen Capital Management LLC, and Christian Olesen, who are interconnected entities and individuals. Olesen Value Fund GP LLC is the general partner of Olesen Value Fund L.P., Olesen Capital Management LLC is the investment manager, and Christian Olesen is the managing member of both Olesen Value Fund GP LLC and Olesen Capital Management LLC. This structure clarifies the indirect beneficial ownership of the shares by the various reporting persons.

Stakeholder Impact

• Shareholders may interpret the insider selling as a signal of reduced confidence or a belief that the stock is fully valued, potentially leading to negative sentiment or selling pressure on the stock.

Key Dates

Recommendation

The insider selling, while pre-planned under a 10b5-1 plan, suggests that a significant owner and director sees value in taking profits at current levels. This action, even if not indicative of a fundamental deterioration, typically creates a cautious sentiment among investors. Given the planned nature and the remaining significant stake, a 'hold' recommendation is appropriate, advising investors to monitor future developments rather than initiating new positions or aggressively selling.

Keywords

Solitron Devices, SODI, Insider Trading, Form 4, Stock Sale, Olesen Value Fund, 10% Owner, Director, Rule 10b5-1